Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 3 7Phase 2 3Phase 4 2Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Sarcoma 2Other hematologic neoplasm 2Genitourinary 2Plasma cell 1Lymphoid 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 389Head and Neck Neoplasms 339Carcinoma, Non-Small-Cell Lung 230Melanoma 155Colorectal Neoplasms 152Breast Neoplasms 138Ovarian Neoplasms 125Neoplasms 103Stomach Neoplasms 101Carcinoma, Renal Cell 101Neoplasm Metastasis 94Pancreatic Neoplasms 93Lung Neoplasms 87Uterine Cervical Neoplasms 81Triple Negative Breast Neoplasms 75Esophageal Neoplasms 75Prostatic Neoplasms 70Urinary Bladder Neoplasms 69Thyroid Neoplasms 62Carcinoma, Squamous Cell 57Carcinoma, Hepatocellular 57Sarcoma 54Endometrial Neoplasms 54Carcinoma, Transitional Cell 54Small Cell Lung Carcinoma 50Salivary Gland Neoplasms 49Colonic Neoplasms 41Nasopharyngeal Carcinoma 38Mouth Neoplasms 37Kidney Neoplasms 34

Interventions

Oxycodone 1Methadone 1Gabapentin 1Amidines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pain × Head & Neck × Clear all
NCT02531906 2022-07-25

Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation

Roswell Park Cancer Institute

Phase 1 Completed
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Pain, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡